Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price target.

byBenzinga Newsdesk

March 9, 2023

1 minute read

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price target.

Cathie Wood Picks Up $13M In Tesla Shares As Investors React Negatively To Q3 Earnings

By Bhavik Nair

October 20, 9:25 PM

Cathie Wood-led ARK Investment Management has bought over 66,000 shares of Tesla Inc (NASDAQ: TSLA) at a valuation of over $13 million, based on Thursday’s closing price, via the company’s flagship

ARKK

US Stocks On Track For Lackluster Start On Data-Heavy Thursday — Retail Earnings, Cisco, Nvidia, Alibaba In Focus

By Shanthi Rexaline

November 17, 6:51 AM

The index futures point to a nervous start by Wall Street stocks on Thursday, as the inflation-induced euphoria fades and traders turn their focus back to the Fed and the rate outlook.

AMAT